AT&T posted better-than-expected earnings on Monday, as the number of customers who signed up for its plans over the final quarter of 2024 topped Wall Street estimates. The stock jumped 6.6% to $24.23 Monday,

If you're looking for an under-the-radar stock that could deliver enormous gains in a defined time frame, the biopharmaceutical industry has you covered. Hardly a week goes by without clinical trial results or a regulatory decision that produces dramatic market movements.

Wall Street is pointing slightly lower in early trading but is on track to close the week with solid gains on healthy quarterly earnings reports from large U.S. corporations.